Investigating Optical and Neural Causes of Vision Loss

研究视力丧失的光学和神经原因

基本信息

  • 批准号:
    9062879
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-01-01 至 2014-12-31
  • 项目状态:
    已结题

项目摘要

Project Summary / Abstract Vision loss has become a major public health problem due to the growth and aging of the population. Age-related macular degeneration (AMD) is the most common cause of vision loss in people over 50 years of age. In the United States, over 10 million people have AMD and over 1.6 million people age 50 and older have late-stage advanced AMD. It is well established that AMD patients with central vision loss use preferred retinal loci (PRL) which are peripheral retinal areas adjacent to the fovea for performing daily activities, such as reading. However, even in healthy eyes, peripheral vision is limited due to reduced neural sampling density compared to the fovea. Additionally, the function of the peripheral retina can be further reduced in patients, owing to degenerative disease processes. These neural substrate losses are coupled with losses in the quality of the optical image on the retina. Optical imperfections increase with age and off-axis viewing, compared to viewing along the optical axis of the eye. The combination of these factors plays a significant role in reducing visual performance of patients with eccentric fixation. The long term goal of the project is to improve the visual performance of veterans with central vision loss by development of innovative approaches that will optimize the benefit of vision rehabilitation techniques. In the current proposal, optical and neural losses will be assessed in AMD patients with central vision loss using novel techniques. Increased optical losses due to age and viewing off the optical axis of the eye will be established with wavefront analysis technology. Increased neural losses due to retinal dysfunction at PRL will be determined based on measurement of visual acuity with blurred stimuli. Improvement in reading speed will be evaluated, conditional on neural losses at PRL and/or the stability of PRL, after compensating for optical losses with our adaptive optics system. The findings will provide knowledge of PRL function and stability that is beneficial for improving the outcome of available vision rehabilitation methods that train patients to better use their PRLs. Also, customized correction of optical imperfections of the eye for effectively improving visual performance can be developed as an approach for better vision rehabilitation of patients. Optimizing vision rehabilitation of our veterans will allow them to maintain function and productivity.
项目概要/摘要 随着年龄的增长和老龄化,视力丧失已成为一个重大的公共卫生问题。 人口。年龄相关性黄斑变性(AMD)是视力丧失的最常见原因 50岁以上的人。在美国,超过 1000 万人患有 AMD 及以上 160 万名 50 岁及以上的人患有晚期晚期 AMD。众所周知 中心视力丧失的 AMD 患者使用首选视网膜位点 (PRL),即周边视网膜 与中央凹相邻的区域,用于进行日常活动,例如阅读。然而,即使在 健康的眼睛,由于神经采样密度的降低,周边视力受到限制 中央凹。此外,患者周边视网膜的功能可能进一步下降, 由于退行性疾病过程。这些神经底物损失与 视网膜上光学图像的质量损失。光学缺陷随着年龄的增长而增加 与沿眼睛光轴观看相比,离轴观看。的组合 这些因素在降低偏心患者的视觉表现方面发挥着重要作用 固定。该项目的长期目标是提高退伍军人的视觉表现 通过开发创新方法来优化中心视力丧失 视力康复技术。在当前的提案中,光学和神经损失将是 使用新技术对中心视力丧失的 AMD 患者进行评估。增加光学 由于年龄和离开眼睛光轴观看而造成的损失将通过波前确定 分析技术。 PRL 时由于视网膜功能障碍而导致的神经损失增加 根据模糊刺激下的视力测量来确定。阅读能力的提高 速度将根据 PRL 的神经损失和/或 PRL 的稳定性进行评估,之后 使用我们的自适应光学系统补偿光学损耗。研究结果将提供 了解 PRL 功能和稳定性,有利于改善可用的结果 训练患者更好地使用其 PRL 的视力康复方法。还有定制的 矫正眼睛的光学缺陷,有效改善视觉表现 开发作为一种更好的患者视力康复方法。优化视力 我们的退伍军人的康复将使他们能够保持功能和生产力。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mahnaz Shahidi其他文献

Mahnaz Shahidi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mahnaz Shahidi', 18)}}的其他基金

Imaging of Retinal Oxygen Metabolism in Diabetic Retinopathy
糖尿病视网膜病变的视网膜氧代谢成像
  • 批准号:
    9886053
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Imaging of Retinal Oxygen Metabolism in Diabetic Retinopathy
糖尿病视网膜病变视网膜氧代谢的成像
  • 批准号:
    10549308
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Imaging of Retinal Oxygen Metabolism in Diabetic Retinopathy
糖尿病视网膜病变视网膜氧代谢的成像
  • 批准号:
    10320926
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Imaging of Retinal Oxygen Metabolism in Diabetic Retinopathy
糖尿病视网膜病变视网膜氧代谢的成像
  • 批准号:
    10077556
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10714513
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Center Core Grant for Vision Research
视觉研究中心核心资助
  • 批准号:
    9788481
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Center Core Grant for Vision Research
视觉研究中心核心资助
  • 批准号:
    10413120
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10178038
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10413124
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Center Core Grant for Vision Research
视觉研究中心核心资助
  • 批准号:
    10714512
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:

相似海外基金

I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
  • 批准号:
    10102692
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
  • 批准号:
    10639785
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
  • 批准号:
    23K09052
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
  • 批准号:
    10642988
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
  • 批准号:
    10584110
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
  • 批准号:
    22H03243
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
  • 批准号:
    10433610
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
  • 批准号:
    10504138
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了